Recombinant Human L2HGDH Protein，His

L2HGDH (L-2-hydroxyglutarate dehydrogenase) is an essential enzyme involved in the metabolism of L-2-hydroxyglutarate (2-HG), a metabolite that has gained attention due to its association with various neurological disorders and certain types of cancers, particularly gliomas. Mutations in the L2HGDH gene can lead to a rare metabolic disorder known as L-2-hydroxyglutaric aciduria, which is characterized by elevated levels of 2-HG in the body, resulting in neurological symptoms and developmental issues. Research into the recombinant production of L2HGDH protein seeks to elucidate its biochemical properties, functional mechanisms, and potential therapeutic applications. By utilizing recombinant DNA technology, scientists can produce large quantities of this enzyme, allowing for detailed studies on its enzymatic activity, structure-function relationships, and interactions with substrates and inhibitors. Furthermore, understanding the role of L2HGDH in cellular metabolism and its implications in disease processes could pave the way for innovative diagnostic and treatment strategies for conditions associated with dysregulation of 2-HG levels. The quest for effective therapies targeting L2HGDH and the pathways it influences has become increasingly relevant in precision medicine, as the knockdown of this enzyme has shown potential in altering metabolic profiles that drive tumorigenesis. Therefore, the study of recombinant L2HGDH not only contributes to basic biological knowledge but also has significant implications for the development of novel therapeutic approaches in oncology and neurology.